Cannabis Capital Corp. (CBCA) Confirms Approval of Name Change with FINRA and Key Executive Appointments; Announces New Trading Symbol 'CBCA'
BEVERLY HILLS, Calif., March 4, 2014 /PRNewswire/ -- Cannabis Capital Corp. (CBCA) fka World Stevia Corp (WSTV) is a Company focused on high-growth acquisitions within the Cannabis Industry.
Effective today, FINRA has approved Cannabis Capital's name change and symbol for trading. The Company is fully reporting and audited, with its shares listed for trading on the OTC with symbol "CBCA" under the leadership of its President & CEO Chad S. Johnson, Esq., and its CFO Robert Kane, backed by an extended team of seasoned investors, associates, and advisors.
This large International emerging market within the cannabis industry has born countless successful business models, and attractive opportunities have developed on a worldwide basis. Within the United States alone, there are over 20 states participating or investing in diverse business activities in the expanding cannabis industry in one manner or another, one that has widely been deemed a breakthrough market for savvy investors. The Cannabis Capital management team has the understanding, expertise, and sophistication required to create the effective strategies for establishing Cannabis Capital as a key player in the market.
"New and emerging markets in the cannabis industry are considered highly valuable; as the industry grows and matures, so will the range, depth and diversity of businesses within it. We have already identified a few key acquisition opportunities to start the process of accelerating our growth plans. We at Cannabis Capital look forward to solidifying a premiere role in the development of the cannabis industry around the world -- in multiple capacities that support and surpass the seed to sale model," said Chad S. Johnson, Esq., President & CEO, Cannabis Capital Corp.
Chad S. Johnson - President, Chief Executive Officer & Director
Mr. Johnson, a graduate of Harvard College and Harvard Law School, followed a federal judicial clerkship with a position as an attorney for the renown law firm of Skadden Arps Slate Meagher & Flom LLP, where Mr. Johnson focused on representation of banking and financial institutions in the context of mergers, acquisitions, and regulatory advice. During his seven years at Skadden, Mr. Johnson also served as founder, pro bono general counsel, and/or director for several civil rights, AIDS, religious, and progressive political organizations, receiving the second pro bono award from the firm to serve as a Skadden Legal Aid Society attorney. Mr. Johnson left the firm in 2000 to work full-time with the Gore/Lieberman campaign and subsequent recount effort. He then served as executive director of the national LGBT Democrats' organization for two years before pursuing various entrepreneurial ventures, while also serving as chief of staff and general counsel for a premier cosmetic surgery center from September 2003 to February 2013, gaining key insight into law and medicine through interaction with patients, physicians, and industry partners. Mr. Johnson co-founded the non-profit World AIDS Institute and Timothy Ray Brown Foundation. He has founded or served on the boards of directors for several political action committees (PACs) and issue-advocacy or lobbying organizations in Washington, DC. Currently, Mr. Johnson holds executive positions on the boards of multiple corporations and non-profit organizations, including Cannabis Science, Inc., Endocan Corporation, and the Future of Nicaragua Foundation.
Robert Kane - Chief Financial Officer & Director
Mr. Kane wrote his first business plan in 1996. In 1998, he was hired at Ryan, Beck, and Company, subsequently acquired by the 120-year-old financial firm, Stifel Nicolaus, as a successful registered representative. In 2009 Mr. Kane walked away from the financial markets to start his own firm to specialize in business and management planning, investor presentations, and investor relations for the cannabis industry. Mr. Kane also held the position of Director of Investor Relations for Medical Marijuana, Inc., the first publicly traded medical marijuana company. Mr. Kane also held the position of Chief Financial Officer for Cannabiz Business University when they hosted the Medical Cannabis Educational Symposium in Hawai'i in 2011. Among many industry accomplishments, Mr. Kane blueprinted one of the industry's early private equity funds and has worked on state legislation in multiple states to provide economic interpretations and projections for the cannabis industry. In 2012, Mr. Kane sold his firm to Cannabis Science, Inc. (CBIS) and consulted in investor relations until his promotion to CFO in 2013. Mr. Kane also sits as a director and CFO for Endocan Corporation, a strategic partner of Cannabis Science.
Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Capital Corp. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
Cannabis Capital Corp.
Chad S. Johnson, President, CEO & Director
Robert Kane, CFO & Director
SOURCE Cannabis Capital Corp.